BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3862847)

  • 1. HLA-DR antigens in polymyalgia rheumatica and giant cell arteritis.
    Gouet D; Alcalay D; Azais I; Alcalay M; Becq-Giraudon B; Sudre Y; Bontoux D
    J Rheumatol; 1985 Jun; 12(3):627-8. PubMed ID: 3862847
    [No Abstract]   [Full Text] [Related]  

  • 2. HLA-DR locus antigens in polymyalgia rheumatica and giant cell arteritis.
    Calamia KT; Moore SB; Elveback LR; Hunder GG
    J Rheumatol; 1981; 8(6):993-6. PubMed ID: 6948960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA antigens in patients with giant cell arteritis and polymyalgia rheumatica.
    Hunder GG; Taswell HF; Pineda AA; Elveback LR
    J Rheumatol; 1977; 4(3):321-3. PubMed ID: 926109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Giant cell arteritis in two brothers.
    Mathewson JA; Hunder GG
    J Rheumatol; 1986 Feb; 13(1):190-2. PubMed ID: 3486285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histocompatibility antigens in polymyalgia rheumatica and giant cell arteritis.
    Armstrong RD; Behn A; Myles A; Panayi GS; Welsh KI
    J Rheumatol; 1983 Aug; 10(4):659-61. PubMed ID: 6413689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased frequency of HLA-DR3 and DR4 in polymyalgia rheumatica-giant cell arteritis.
    Lowenstein MB; Bridgeford PH; Vasey FB; Germain BF; Espinoza LR
    Arthritis Rheum; 1983 Jul; 26(7):925-7. PubMed ID: 6603224
    [No Abstract]   [Full Text] [Related]  

  • 7. Association of polymyalgia rheumatica and giant-cell arteritis with HLA-B8.
    Hazleman B; Goldstone A; Voak D
    Br Med J; 1977 Oct; 2(6093):989-91. PubMed ID: 922399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies to cardiolipin and beta 2 glycoprotein I in patients with polymyalgia rheumatica and giant cell arteritis.
    Meyer O; Nicaise P; Moreau S; de Bandt M; Palazzo E; Hayem G; Chazerain P; Labarre C; Kahn MF
    Rev Rhum Engl Ed; 1996 Apr; 63(4):241-7. PubMed ID: 8738442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymyalgia rheumatica and giant cell arteritis: circulating immune complexes.
    Espinoza LR; Bridgeford P; Lowenstein M; Bocanegra TS; Vasey FB; Germain BF
    J Rheumatol; 1982; 9(4):556-60. PubMed ID: 6215486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-DRB1 alleles in polymyalgia rheumatica, giant cell arteritis, and rheumatoid arthritis.
    Weyand CM; Hunder NN; Hicok KC; Hunder GG; Goronzy JJ
    Arthritis Rheum; 1994 Apr; 37(4):514-20. PubMed ID: 8147928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymyalgia rheumatica and temporal arteritis in blacks--clinical features and HLA typing.
    Sanford RG; Berney SN
    J Rheumatol; 1977; 4(4):435-42. PubMed ID: 604481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymyalgia rheumatica and giant cell arteritis: histocompatibility typing and hepatitis-B infection studies.
    Bridgeford PH; Lowenstein M; Bocanegra TS; Vasey FB; Germain BF; Espinoza LR
    Arthritis Rheum; 1980 Apr; 23(4):516-8. PubMed ID: 7370065
    [No Abstract]   [Full Text] [Related]  

  • 13. HLA-DR4 in giant cell arteritis: association with polymyalgia rheumatica syndrome.
    Richardson JE; Gladman DD; Fam A; Keystone EC
    Arthritis Rheum; 1987 Nov; 30(11):1293-7. PubMed ID: 3500727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-neutrophil cytoplasm antibodies in giant cell arteritis and polymyalgia rheumatica.
    Meyer O; De Bandt M; Haim T; Kahn MF
    Ann Med Interne (Paris); 1992; 143(7):476. PubMed ID: 1300870
    [No Abstract]   [Full Text] [Related]  

  • 15. [Polymyalgia rheumatica and giant cell arteritis--first results of a year-long study].
    Rovenský J; Tuchynová A; Poprac P; Blazíková S; Bosák V; Stvrtinová V
    Vnitr Lek; 2006; 52(7-8):691-6. PubMed ID: 16967610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymyalgia rheumatica: a syndrome associated with HLA-DR4 antigen.
    Cid MC; Ercilla G; Vilaseca J; Sanmarti R; Villalta J; Ingelmo M; Urbano-Marquez A
    Arthritis Rheum; 1988 May; 31(5):678-82. PubMed ID: 3259885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of consistent peripheral blood lymphocyte transformation responses in polymyalgia rheumatica and giant cell arteritis.
    Jones JG; Park JR; Hazelman BL; Ward M; Bulgen DY
    J Rheumatol; 1980; 7(6):891-4. PubMed ID: 7205827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and environmental factors in polymyalgia rheumatica.
    Cimmino MA
    Ann Rheum Dis; 1997 Oct; 56(10):576-7. PubMed ID: 9389216
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hutchinson-Horton giant cell arteritis and rhizomelic polymyalgia. III. Current pathogenetic and nosographic aspects].
    Lovisetto P; Marchi L; Gilardi E; Mairano D; Biarese V
    Minerva Med; 1984 May; 75(19):1103-10. PubMed ID: 6728260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular analysis of HLA-DR polymorphism in polymyalgia rheumatica. Swiss Group for Research on HLA in Polymyalgia Rheumatica.
    Guerne PA; Salvi M; Seitz M; Bruhlmann P; Rivier G; Frey D; Mermillod B; Vischer TL; Tiercy JM
    J Rheumatol; 1997 Apr; 24(4):671-6. PubMed ID: 9101500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.